Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2 ; volume:21 ; number:1 ; day:25 ; month:1 ; year:2024 ; pages:1-13 ; date:12.2024
Virology journal ; 21, Heft 1 (25.1.2024), 1-13, 12.2024
- Urheber
-
Roy, Annie V.
Chan, Michael
Banadyga, Logan
He, Shihua
Zhu, Wenjun
Chrétien, Michel
Mbikay, Majambu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-024-02299-w
- URN
-
urn:nbn:de:101:1-2024040512302829875565
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Roy, Annie V.
- Chan, Michael
- Banadyga, Logan
- He, Shihua
- Zhu, Wenjun
- Chrétien, Michel
- Mbikay, Majambu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2
Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation
ACE2: the molecular doorway to SARS-CoV-2
Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice
Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2
Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation
ACE2: the molecular doorway to SARS-CoV-2
Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice
Inhalation of ACE2-expressing lung exosomes provides prophylactic protection against SARS-CoV-2
Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
Computational decomposition reveals reshaping of the SARS‐CoV‐2–ACE2 interface among viral variants expressing the N501Y mutation
ACE2: the molecular doorway to SARS-CoV-2
Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
Investigation of Interaction between the Spike Protein of SARS-CoV-2 and ACE2-Expressing Cells Using an In Vitro Cell Capturing System
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry